Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT-1: Rolofylline in Acute Heart Failure with Renal Impairment
NCT00328692Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2006
- Primary completion
- Jul 2009
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of rolofylline in acute heart failure (AHF), sponsored by Merck & Co.. Started Aug 2006; status: completed.
02
Drugs
rolofylline
03
Conditions
acute heart failure (AHF)
Beyond the preview
Go deeper on NCT00328692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00328692.